Because of the cardio-protective effects exerted by BNP, we hypothesized that the increased risk of IHD in individuals with obesity is due not only to well-known risk factors (e.g., hypertension, dyslipidaemia, diabetes) but also to the compromised cardio-protection of the reduced BNP level. This evidence concerns the gene NPPB and inherited lipid metabolism disorder.